JPH01207238A - Material for preventing decubitus - Google Patents
Material for preventing decubitusInfo
- Publication number
- JPH01207238A JPH01207238A JP63033552A JP3355288A JPH01207238A JP H01207238 A JPH01207238 A JP H01207238A JP 63033552 A JP63033552 A JP 63033552A JP 3355288 A JP3355288 A JP 3355288A JP H01207238 A JPH01207238 A JP H01207238A
- Authority
- JP
- Japan
- Prior art keywords
- decubitus
- polyurethane foam
- chitosan
- powder
- polyurethane
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000463 material Substances 0.000 title claims abstract description 7
- 206010011985 Decubitus ulcer Diseases 0.000 title abstract description 6
- 239000000843 powder Substances 0.000 claims abstract description 6
- 229920005830 Polyurethane Foam Polymers 0.000 claims abstract description 5
- 239000011496 polyurethane foam Substances 0.000 claims abstract description 5
- 208000004210 Pressure Ulcer Diseases 0.000 claims description 10
- 229920001661 Chitosan Polymers 0.000 abstract description 9
- 229920002635 polyurethane Polymers 0.000 abstract description 8
- 239000004814 polyurethane Substances 0.000 abstract description 8
- 230000000844 anti-bacterial effect Effects 0.000 abstract description 6
- 239000003513 alkali Substances 0.000 abstract description 3
- 150000001875 compounds Chemical class 0.000 abstract description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 3
- 241000894006 Bacteria Species 0.000 abstract description 2
- 239000004604 Blowing Agent Substances 0.000 abstract description 2
- 229920002101 Chitin Polymers 0.000 abstract description 2
- 239000002253 acid Substances 0.000 abstract description 2
- 150000001412 amines Chemical class 0.000 abstract description 2
- 239000003431 cross linking reagent Substances 0.000 abstract description 2
- 230000000850 deacetylating effect Effects 0.000 abstract description 2
- 239000003960 organic solvent Substances 0.000 abstract description 2
- 210000004243 sweat Anatomy 0.000 abstract description 2
- 239000004480 active ingredient Substances 0.000 abstract 2
- 241000238421 Arthropoda Species 0.000 abstract 1
- 241000238424 Crustacea Species 0.000 abstract 1
- 208000002193 Pain Diseases 0.000 abstract 1
- 241000589516 Pseudomonas Species 0.000 abstract 1
- NBVXSUQYWXRMNV-UHFFFAOYSA-N fluoromethane Chemical compound FC NBVXSUQYWXRMNV-UHFFFAOYSA-N 0.000 abstract 1
- 229950006780 n-acetylglucosamine Drugs 0.000 abstract 1
- 230000036407 pain Effects 0.000 abstract 1
- 229920000642 polymer Polymers 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- 239000000725 suspension Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 3
- 241000191940 Staphylococcus Species 0.000 description 3
- 239000006260 foam Substances 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 2
- 239000004088 foaming agent Substances 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- WTOIRKBUWMPVHG-VEIQOZLZSA-N (3R,4R,5S,6R)-3-amino-2-hexadecyl-6-(hydroxymethyl)oxane-2,4,5-triol Chemical compound CCCCCCCCCCCCCCCCC1(O)O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1N WTOIRKBUWMPVHG-VEIQOZLZSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- UHPMCKVQTMMPCG-UHFFFAOYSA-N 5,8-dihydroxy-2-methoxy-6-methyl-7-(2-oxopropyl)naphthalene-1,4-dione Chemical compound CC1=C(CC(C)=O)C(O)=C2C(=O)C(OC)=CC(=O)C2=C1O UHPMCKVQTMMPCG-UHFFFAOYSA-N 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 208000028399 Critical Illness Diseases 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- -1 Freon Chemical class 0.000 description 1
- 241000223218 Fusarium Species 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 229920001730 Moisture cure polyurethane Polymers 0.000 description 1
- 101100128278 Mus musculus Lins1 gene Proteins 0.000 description 1
- 239000004721 Polyphenylene oxide Substances 0.000 description 1
- 206010040893 Skin necrosis Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 235000011054 acetic acid Nutrition 0.000 description 1
- 230000021736 acetylation Effects 0.000 description 1
- 238000006640 acetylation reaction Methods 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- QBWCMBCROVPCKQ-UHFFFAOYSA-N chlorous acid Chemical compound OCl=O QBWCMBCROVPCKQ-UHFFFAOYSA-N 0.000 description 1
- 229940077239 chlorous acid Drugs 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000006196 deacetylation Effects 0.000 description 1
- 238000003381 deacetylation reaction Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 125000005442 diisocyanate group Chemical group 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 229960002442 glucosamine Drugs 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 210000004705 lumbosacral region Anatomy 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 239000004745 nonwoven fabric Substances 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920005906 polyester polyol Polymers 0.000 description 1
- 229920000570 polyether Polymers 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 150000003077 polyols Chemical class 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 210000000954 sacrococcygeal region Anatomy 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 208000020431 spinal cord injury Diseases 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 230000007306 turnover Effects 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Invalid Beds And Related Equipment (AREA)
Abstract
Description
本発明は、医療用材料、殊に寝たきり老人その他、長期
横臥患者用の褥槍(床擦れ)防止材に関する。The present invention relates to medical materials, particularly bedsore prevention materials for bedridden elderly and other long-term recumbent patients.
(背景)
ijlT(床擦れ; decubitus)は、絶対安
静状態の重症患者、を髄損傷患者、寝たきり老人などの
自刃で寝返ることのできない長期就床者に発生する皮膚
壊厄至壊瘍であって、殊に仙骨部位に好発しやすい、そ
して−旦褥槍が発生すると、ドレンシング型パップ材を
傷口に占てで手当しても内的な栄養不良の影響もあって
、容易には治癒しない。
(従来技術の問題点)
それ故、褥槍は治療よりも発生を予防することが先決で
あって、そのための手段として順回の体位交換、清拭、
特殊な寝返りベツドの使用(医歯薬出版−刊(最新医学
大辞典)676頁)などが推奨されているが、何れにし
ても介護者に多大の肉体的又は経済的負担を4えること
になる。この他、エアーマットで身体を多面から支える
ことにより局所的な荷重の集中を阻止したり、発泡ウレ
タンシートを敷いてクツション性を良くしようという試
みもなされているが、エアーマットでは身体が揺れ動い
て患者を落着かせず、また発泡ウレタンシートも、褥槍
の発生を多少遅らせるだけの効果しかない。
今や、高齢化社会に突入した現在1回復の望めない寝た
きり老人の数が益々増加することは避けられない趨性で
あるが、こうした長期就床者は多少ともi[に悩まされ
ているから、人生の終、1.5を苦痛に虐まれて迎える
ことは1本人の苦痛はもとより、家族等の周辺の人々に
とっても耐え難いことである。(Background) ijlT (bed sore; decubitus) is a skin necrosis that occurs in critically ill patients who are on absolute bed rest, patients with spinal cord injuries, and long-term bedridden patients who cannot turn over by themselves, such as bedridden elderly people. It is particularly likely to occur in the sacral region, and when it occurs, it does not heal easily due to the effects of internal malnutrition even if a draining type poultice is applied to the wound. (Problems with the prior art) Therefore, it is better to prevent the occurrence of bedsores than to treat them, and the means to achieve this are to change the body position regularly, cleanse the body,
Although it is recommended to use a special bed that can be turned over (Ishiyaku Publishing Co., Ltd. (Latest Medical Dictionary), p. 676), in any case, it places a great physical or financial burden on the caregiver. Become. In addition, attempts have been made to prevent the concentration of local loads by supporting the body from multiple sides with air mats, and to improve cushioning properties by laying urethane foam sheets, but air mats do not allow the body to sway. The patient is not calmed down, and the urethane foam sheet only has the effect of slightly delaying the development of bedsores. Now that we have entered an aging society, it is an inevitable trend that the number of bedridden elderly people with no hope of recovery will continue to increase. Reaching the end of one's life in such agony is not only painful for the individual, but also unbearable for the family and other people around them.
以上の実情に鑑み、本発明は、褥槍の発生を効果的に抑
制しうる手段を提供するのを目的とする。
(概要)
以上の課題を解決するため、本発明は、キトサン酸塩粉
末が分散しているシート状の発泡ポリウレタンからなる
ことを特徴とする褥噴防止材を要旨とする。
(発泡シートの製造)
本発明で用いるキトサンを担持した発泡ポリウレタンは
、例えば■ポリウレタンプレポリマーを有機溶剤に溶か
し、この溶液にキトサン酸塩粉末を懸濁させたものに、
アミン、水等の架橋剤、フレオン等の発泡剤を加えるか
、又は■ポリウレタンを自己乳化もしくは強制乳化させ
た水分散体に、キトサン酸塩粉末を懸濁させ、これらを
適当なJ’/さに展延、成膜し又は2に trt上に塗
ノTj、乾燥させることにより製造される。
(ポリウレタン)
本発明シートの基材であるポリウレタンは、特別な構造
を持つ必要はなく、極く普通のポリエーテルポリオール
又はポリエステルポリオールにTDI()リレンジイソ
シアネート)もしくはMDI(ジフェニルメタジイソシ
アネート)を加え1反応させて末端インシアネート基を
有するウレタンプレポリマーを造り、これを上記のよう
に加工すればよい。
(キトサン及びその酸111)
ここに用いるキトサンは、カニ、エビ等の甲殻類動物の
殻、昆虫等の節足動物の外皮、カビやキノコの菌糸等よ
り得られるキチンCM状ポリ−(β−1,4−N−7セ
チルグルコサミン))を濃厚アルカリで脱アセチル化し
て得られるポリ−(β−1,4−グルコサミン)で、分
子fiヒトー万〜数十万のものを、アルカリ、酸、過酸
化水素、亜塩素酸等で適当な分子!11迄解重合(減粘
)して用いる。
本発明の目的上、使用するキトサンの分子量は1.00
0以上10万以丁であることが好ましい、かつキトサン
の脱アセチル化度が、50%以上、好ましくは70%以
上である。
以にのキトサンは、そのままでは水に溶けないので、塩
酸などの無機酸又は蟻酸、酢酸もしくは乳酸などの有機
酸の酩mに変じて水溶性とする。
キトサン酸塩の抗菌性及び抗カビ性については、既に大
室ら(昭和80年度キチン、キトサン及び関連酵素の基
礎、応用研究の新展開研究成果報告書12頁参照)によ
り発表されており、細菌では大腸菌、納豆菌、緑購菌、
ブドウ状球菌等に、カビではフザリウム類に効果がある
ことが明らかになっているが、自体乾燥状態では抗菌性
はなく。
周囲の木に溶けた状態で始めて抗菌性を発揮するもので
ある。なお、L記の6閑に対するMIC(最小阻止C度
)は、200〜400 ppm程度であって、ヒト及び
高等動物にたいしては完全に無害である。
以上のキトサン酸塩の抗菌スペクトルは、褥瑣を起こす
菌には緑膿菌及びブドウ状球菌が多い(日本薬学会第1
07年会講演要旨4J(1987)、800頁参照)関
係で、褥炬防止のため極めて効果的である。
キトサン酸塩の粒度は細かい方がよく、通常JIS標を
篩で48メツシ1以下が好ましい、かつ、そのポリウレ
タン中での含量は、1〜30%の間で任意に選択される
0本酸塩の量が−Eの範囲未満では効果が乏しく、逆に
該範囲を超えると、発泡が不用部なる他、添加効率が低
下して不経済となる。
(発泡シート)
本発明シートの厚みは、汀通0.2〜10III6の間
で選ばれるのがよい、厚みが薄すぎると、身体へのちり
が強くなって褥槍防止効果が低下し、他方、厚すぎると
、担持されたキトサン酸塩を有効に利用できなくなる。
本発明シートは、適当な大きさに切断し、褥槍が発生し
易い皮f?、7面に直接貼付したり、寝巻やおむつで保
持したりして用いる。In view of the above circumstances, an object of the present invention is to provide a means for effectively suppressing the occurrence of bedsores. (Summary) In order to solve the above-mentioned problems, the gist of the present invention is a bed-splash prevention material characterized by being made of a sheet-like polyurethane foam in which chitosanate powder is dispersed. (Production of foamed sheet) The foamed polyurethane supporting chitosan used in the present invention can be prepared by, for example, (1) dissolving a polyurethane prepolymer in an organic solvent and suspending chitosanate powder in this solution;
Add a crosslinking agent such as amine, water, or a blowing agent such as Freon, or suspend the chitosanate powder in an aqueous dispersion made by self-emulsifying or force-emulsifying polyurethane. It is manufactured by spreading and forming a film or coating it on trt and drying it. (Polyurethane) The polyurethane that is the base material of the sheet of the present invention does not need to have a special structure, and is made by adding TDI (lylene diisocyanate) or MDI (diphenylmethadiisocyanate) to a very ordinary polyether polyol or polyester polyol. The reaction may produce a urethane prepolymer having terminal incyanate groups, which may be processed as described above. (Chitosan and its acid 111) The chitosan used here is chitin CM-like poly(β- Poly-(β-1,4-glucosamine) obtained by deacetylating 1,4-N-7 cetylglucosamine)) with a concentrated alkali. Suitable molecules such as hydrogen peroxide and chlorous acid! It is used after depolymerization (thinning) to 11. For the purposes of the present invention, the molecular weight of the chitosan used is 1.00.
It is preferably 0 or more and 100,000 or more, and the degree of deacetylation of chitosan is 50% or more, preferably 70% or more. Since the above chitosan is not soluble in water as it is, it is made water-soluble by converting it into an inorganic acid such as hydrochloric acid or an organic acid such as formic acid, acetic acid or lactic acid. The antibacterial and antifungal properties of chitosanate have already been published by Omuro et al. Then, Escherichia coli, Bacillus natto, Bacillus aeruginosa,
Although it has been shown to be effective against Staphylococcus and other molds such as Fusarium, it has no antibacterial properties when dried. It only exhibits its antibacterial properties when it is dissolved in the surrounding wood. Incidentally, the MIC (minimum inhibition degree C) for the six compounds listed in L is about 200 to 400 ppm, and is completely harmless to humans and higher animals. The above antibacterial spectrum of chitosanate shows that the bacteria that cause bedsores are Pseudomonas aeruginosa and Staphylococcus (Pharmaceutical Society of Japan No. 1
(Refer to Abstracts of the 2007 Meeting 4J (1987), p. 800), it is extremely effective in preventing bedsores. The particle size of the chitosanate is preferably finer, and is preferably 48 mesh 1 or less when sieved according to the JIS standard, and the content in the polyurethane is arbitrarily selected between 1 and 30%. If the amount is less than -E, the effect will be poor, and if it exceeds the range, foaming will become unnecessary, and addition efficiency will decrease, resulting in uneconomical results. (Foamed sheet) The thickness of the sheet of the present invention is preferably selected between 0.2 and 10III6. If the thickness is too thin, the dust on the body will be strong and the anti-bedsore effect will be reduced. , if it is too thick, the supported chitosanate cannot be utilized effectively. The sheet of the present invention is cut into an appropriate size and the sheet is cut into a suitable size to remove the skin f? , by attaching it directly to the surface or holding it in a nightgown or diaper.
本発明の褥痢予防用ポリウレタンシートでは、その内部
に担持されたキトサン酸塩が患者の汗などによって湿潤
、溶解して徐々に抗菌性を発揮し、緑膿菌及びブドウ状
球菌等の褥槍病原菌の発育を効果的かつ持久的に抑制す
るから、後記In the polyurethane sheet for preventing decubitus ulcers of the present invention, the chitosanate supported inside the sheet becomes wetted and dissolved by the patient's sweat and gradually exhibits antibacterial properties, thereby preventing decubitus infections such as Pseudomonas aeruginosa and Staphylococcus. Because it effectively and sustainably suppresses the growth of pathogenic bacteria,
【実施例】項記載の如く優れた褥石防止効
果を発揮する。[Example] As described in the section, it exhibits an excellent anti-fleckstone effect.
以r、本発明の実施例を示すが1例示は当然説明用のも
のであって、発明思想の制限又は限定を意味するもので
はない。
水分散型ポリウレタン(出願大会社製(スーパーフレッ
クスE−2000>) ”固型分50%)390重i1
1部に、(キトサンKw−5>> (新日本化学■製
、分子量約5万、アセチル化度80%1粒度48メツシ
ユパスのキトサン乳酸塩)4.5重量部を(スコアミン
フォーマーRF)@(起泡剤、出願大会社製) 5.0
−!11量部(グイフロン113)■(発泡剤、ダイキ
ン工業■製)2.5i(置部及び(スーパーフレックス
VF)> ” (増粘剤、出願大会社製)4重量部を、
電動式家庭用撹拌機により高速撹拌してオーバラン約3
00$の生クリーム状態にした。これを5mmの厚みに
ポリエステル製不織布上にコーティングした後、乾燥さ
せ、厚み31の通気性発泡体シートを得た。 以上のシ
ートを、寝たきり患者100名のamを起しやすい部位
(主として腰仙部)の皮膚に直接当てがい、−週間に一
度交換しながら半年間観察を続けた。結果は下記の通り
であった。
有 効(褥槍なし)52例
やや有効(褥槍なし)38例
無 効(褥槍あり)10例
即ち、全100例中、90%の者にT’jlnが発生し
ないという良好な結果が得られた。Hereinafter, embodiments of the present invention will be shown, but the examples are for illustration only and do not imply any limitation or limitation on the inventive concept. Water-dispersed polyurethane (manufactured by Osaka Daisha (Superflex E-2000) "Solid content 50%) 390 weight i1
4.5 parts by weight of (Chitosan Kw-5 >> (manufactured by Shin Nippon Kagaku ■, molecular weight approximately 50,000, degree of acetylation 80%, particle size 48 mesh pass) 4.5 parts by weight (Scoremin Former RF) @ (Foaming agent, manufactured by a major company) 5.0
-! 11 parts by weight (Guiflon 113) ■ (foaming agent, manufactured by Daikin Industries ■) 2.5i (Okibe and (Superflex VF) > 4 parts by weight (thickening agent, manufactured by Daikin Industries),
Stir at high speed with an electric household stirrer and overrun approximately 3 times.
00$ fresh cream state. This was coated on a polyester nonwoven fabric to a thickness of 5 mm, and then dried to obtain a breathable foam sheet having a thickness of 31 mm. The above-mentioned sheets were applied directly to the skin of 100 bedridden patients in areas prone to AM (mainly the lumbosacral region), and observation was continued for half a year while changing them once a week. The results were as follows. The results were good, with 52 cases being effective (no bulges), somewhat effective (no linings) in 38 cases, and 10 cases being ineffective (with lins), that is, 90% of the 100 cases did not develop T'jln. Obtained.
【発11の効果】
以り説明した通り1本発りjは、優れた予防効果を奏す
る褥槍予防材を提供しうることにより、寝たきり名人そ
の他の長期就床者の音節+51減乃至介護者の疲労低減
にrt献しうる。[Effects of 11 syllables] As explained above, 1 ppun j is able to provide a bedjar prevention material with excellent preventive effects, resulting in a reduction of +51 syllables for bedridden masters and other long-term bedridden patients, or a reduction of 51 syllables for caregivers. This can contribute to reducing fatigue.
Claims (1)
リウレタンからなることを特徴とする褥瘡防止材。1. An anti-bedsore material comprising a sheet-like polyurethane foam in which chitosanate powder is dispersed.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP63033552A JP2654789B2 (en) | 1988-02-15 | 1988-02-15 | Anti-decubitus material |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP63033552A JP2654789B2 (en) | 1988-02-15 | 1988-02-15 | Anti-decubitus material |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH01207238A true JPH01207238A (en) | 1989-08-21 |
JP2654789B2 JP2654789B2 (en) | 1997-09-17 |
Family
ID=12389716
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP63033552A Expired - Fee Related JP2654789B2 (en) | 1988-02-15 | 1988-02-15 | Anti-decubitus material |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2654789B2 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH04348165A (en) * | 1990-07-03 | 1992-12-03 | Nitta Gelatin Inc | Production of modified synthetic resin composition, molded article of modified synthetic resin, product of modified synthetic resin and product of modified synthetic resin |
JPH0592925A (en) * | 1991-05-31 | 1993-04-16 | Tottori Univ | Therapeutic agent for wound |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS55122556A (en) * | 1979-03-16 | 1980-09-20 | Nippon Tennen Gas Kogyo Kk | Sterilizing sheettlike substance |
JPS56118627U (en) * | 1980-02-13 | 1981-09-10 | ||
JPS5927827A (en) * | 1982-08-10 | 1984-02-14 | Shigeo Suzuki | Anti-infective agent |
JPS61244351A (en) * | 1985-04-22 | 1986-10-30 | 中西 美智夫 | Medical mat |
-
1988
- 1988-02-15 JP JP63033552A patent/JP2654789B2/en not_active Expired - Fee Related
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS55122556A (en) * | 1979-03-16 | 1980-09-20 | Nippon Tennen Gas Kogyo Kk | Sterilizing sheettlike substance |
JPS56118627U (en) * | 1980-02-13 | 1981-09-10 | ||
JPS5927827A (en) * | 1982-08-10 | 1984-02-14 | Shigeo Suzuki | Anti-infective agent |
JPS61244351A (en) * | 1985-04-22 | 1986-10-30 | 中西 美智夫 | Medical mat |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH04348165A (en) * | 1990-07-03 | 1992-12-03 | Nitta Gelatin Inc | Production of modified synthetic resin composition, molded article of modified synthetic resin, product of modified synthetic resin and product of modified synthetic resin |
JPH0592925A (en) * | 1991-05-31 | 1993-04-16 | Tottori Univ | Therapeutic agent for wound |
Also Published As
Publication number | Publication date |
---|---|
JP2654789B2 (en) | 1997-09-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5827409B2 (en) | Wound dressing with air permeable layer | |
JP5827408B2 (en) | Multilayer wound dressing with hydrophilic colloid and activated carbon | |
EP2805734B1 (en) | Antimicrobial wound-covering material and method for manufacturing same | |
US7517536B2 (en) | Antimicrobial compositions and wound dressings | |
JP6067018B2 (en) | Wound dressing with antibacterial effect | |
US20070122463A1 (en) | Antimicrobial compositions and wound dressings | |
CN1322474A (en) | Aggregation-preventing nanometer wide-spectrum antibacterial silve powder and its inductrial production process | |
AU2007200085B2 (en) | Antimicrobial compositions and wound dressings | |
US9839715B2 (en) | Anti-microbial foams containing polymer-stabilized silver nanoparticles | |
CA2014114A1 (en) | Polymeric broad-spectrum antimicrobial materials | |
WO2021096897A1 (en) | Antimicrobial and antiviral, biologically active polymer composites effective against sars-cov-2 and other viral, bacterial and fungal targets, and related methods, materials, coatings and devices | |
JPH01207238A (en) | Material for preventing decubitus | |
Attayil Sukumaran et al. | Wound dressings based on chitosan/gelatin/MgO composite films | |
CN105254913B (en) | A kind of surface has polyester material and the preparation and application of antibiotic property and biocompatibility concurrently | |
CN113163769A (en) | Antimicrobial materials | |
EP2981302B1 (en) | Microbicidal composite material | |
CN108755164B (en) | Macromolecular latex foaming product for degrading formaldehyde and TVOC and inhibiting germs and preparation method thereof | |
JPH0751139B2 (en) | Wound dressing | |
JPH03146057A (en) | Wound coating material and production thereof | |
JPH0745006U (en) | Health mask | |
BR102016030195B1 (en) | MICROPOROUS MEMBRANE, PROCESS FOR OBTAINING MICROPOROUS MEMBRANE AND WATER DISINFECTION PROCESS | |
Mišković-Stanković | Faculty of Ecology and Environmental Protection, University “Union-Nikola Tesla”, Cara Dušana 62-64, 11000 Belgrade, Serbia.* vesna. miskovicstankovic@ gmail. com | |
KR20080006454U (en) | A Bactericide mattress for medical treatment |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
LAPS | Cancellation because of no payment of annual fees |